Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Reproductive Immunology"
DOI: 10.1111/aji.13559
Abstract: We evaluated eculizumab, a complement protein C5 inhibitor, for treatment of severe COVID‐19 in pregnant and postpartum individuals. read more here.
Keywords: eculizumab treatment; complement; blockade eculizumab; complement blockade ... See more keywords